US Stock MarketDetailed Quotes

PBLA Panbela Therapeutics

Watchlist

0.370
+0.030+8.67%

15min DelayClose Jul 22 16:00 ET

1.79MMarket Cap0.00P/E (TTM)

Panbela Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

3.68%-9.39M

-65.29%-25.25M

38.44%-3.08M

-319.15%-6.68M

-36.79%-5.74M

-117.51%-9.75M

-110.85%-15.28M

-124.55%-5M

-17.22%-1.59M

-147.90%-4.2M

Net income from continuing operations

-39.25%-7.12M

27.68%-25.26M

-36.73%-6.47M

-78.03%-7.84M

73.62%-5.84M

-39.47%-5.11M

-244.68%-34.93M

-33.83%-4.74M

-104.36%-4.4M

-912.35%-22.13M

Operating gains losses

----

---400K

----

Other non cash items

-19.05%34K

-12.82%238K

164.77%466K

-498.81%-335K

--65K

--42K

--273K

--176K

--84K

----

Change In working capital

50.43%-2.41M

-215.74%-647K

574.67%3.2M

-47.70%1.31M

-169.09%-296K

-322.24%-4.86M

-65.13%559K

-169.30%-675K

442.39%2.5M

-185.27%-110K

-Change in receivables

---140K

-162.26%-132K

77.78%-20K

-88.96%37K

---149K

--0

315.69%212K

-135.71%-90K

570.00%335K

--0

-Change in prepaid assets

56.74%-912K

-100.74%-5.4M

-124.18%-5.02M

1,214.66%2.59M

-135.34%-859K

20.45%-2.11M

-817.41%-2.69M

-335.21%-2.24M

-354.95%-232K

8,003.33%2.43M

-Change in payables and accrued expense

-150.46%-1.36M

60.82%4.88M

396.81%2.7M

-155.10%-1.32M

3,960.00%812K

75.52%2.69M

64.50%3.04M

-173.54%-909K

649.84%2.39M

-91.56%20K

-Change in other current assets

--0

----

--0

---100K

---5.44M

----

--0

----

Cash from discontinued investing activities

Operating cash flow

3.68%-9.39M

-65.29%-25.25M

38.44%-3.08M

-319.15%-6.68M

-36.79%-5.74M

-117.51%-9.75M

-110.85%-15.28M

-124.55%-5M

-17.22%-1.59M

-147.90%-4.2M

Investing cash flow

Cash flow from continuing investing activities

160.98%400K

40,100.00%400K

-656K

-1K

Net intangibles purchase and sale

----

160.61%400K

--0

40,100.00%400K

----

---660K

--0

---1K

----

Net business purchase and sale

----

--0

----

--4K

--0

----

Cash from discontinued investing activities

Investing cash flow

----

160.98%400K

--0

40,100.00%400K

----

---656K

--0

---1K

----

Financing cash flow

Cash flow from continuing financing activities

-48.32%7.08M

388.27%26.14M

-11.22%4.75M

-480.00%-19K

7.71M

13.7M

-46.97%5.35M

534,800.00%5.35M

-99.94%5K

Net issuance payments of debt

39.39%-1M

---1.65M

--0

---1.65M

--0

Net common stock issuance

-47.36%8.08M

330.79%23.04M

-100.17%-9K

---19K

--7.72M

--15.35M

-40.92%5.35M

534,800.00%5.35M

--0

Proceeds from stock option exercised by employees

----

94,880.00%4.75M

--4.75M

----

-99.52%5K

--0

----

Net other financing activities

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-48.32%7.08M

388.27%26.14M

-11.22%4.75M

-480.00%-19K

--7.71M

--13.7M

-46.97%5.35M

534,800.00%5.35M

-99.94%5K

--0

Net cash flow

Beginning cash position

100.62%2.58M

-89.17%1.29M

-3.61%907K

184.78%7.21M

-29.12%5.24M

-89.17%1.29M

31.53%11.87M

-93.31%941K

-60.50%2.53M

-8.79%7.39M

Current changes in cash

-158.44%-2.31M

112.22%1.29M

382.37%1.67M

-296.22%-6.3M

140.54%1.97M

188.18%3.95M

-471.03%-10.58M

115.54%346K

-120.65%-1.59M

-186.59%-4.85M

Effect of exchange rate changes

-100.00%-6K

--0

200.00%2K

---2K

175.00%3K

-250.00%-3K

33.33%-4K

-109.09%-2K

--0

---4K

End cash Position

-95.00%262K

100.62%2.58M

-3.61%907K

184.78%7.21M

-29.12%5.24M

-89.17%1.29M

-93.31%941K

-60.50%2.53M

Free cash flow

3.68%-9.39M

-58.44%-25.25M

38.44%-3.08M

-318.88%-6.68M

-18.22%-5.74M

-117.51%-9.75M

-119.96%-15.94M

-124.55%-5M

-17.29%-1.59M

-186.83%-4.86M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	3.68%-9.39M	-65.29%-25.25M	38.44%-3.08M	-319.15%-6.68M	-36.79%-5.74M	-117.51%-9.75M	-110.85%-15.28M	-124.55%-5M	-17.22%-1.59M	-147.90%-4.2M
Net income from continuing operations	-39.25%-7.12M	27.68%-25.26M	-36.73%-6.47M	-78.03%-7.84M	73.62%-5.84M	-39.47%-5.11M	-244.68%-34.93M	-33.83%-4.74M	-104.36%-4.4M	-912.35%-22.13M
Operating gains losses	----	---400K	----	----	----	----	----	----	----	----
Other non cash items	-19.05%34K	-12.82%238K	164.77%466K	-498.81%-335K	--65K	--42K	--273K	--176K	--84K	----
Change In working capital	50.43%-2.41M	-215.74%-647K	574.67%3.2M	-47.70%1.31M	-169.09%-296K	-322.24%-4.86M	-65.13%559K	-169.30%-675K	442.39%2.5M	-185.27%-110K
-Change in receivables	---140K	-162.26%-132K	77.78%-20K	-88.96%37K	---149K	--0	315.69%212K	-135.71%-90K	570.00%335K	--0
-Change in prepaid assets	56.74%-912K	-100.74%-5.4M	-124.18%-5.02M	1,214.66%2.59M	-135.34%-859K	20.45%-2.11M	-817.41%-2.69M	-335.21%-2.24M	-354.95%-232K	8,003.33%2.43M
-Change in payables and accrued expense	-150.46%-1.36M	60.82%4.88M	396.81%2.7M	-155.10%-1.32M	3,960.00%812K	75.52%2.69M	64.50%3.04M	-173.54%-909K	649.84%2.39M	-91.56%20K
-Change in other current assets	--0	----	----	--0	---100K	---5.44M	----	----	--0	----
Cash from discontinued investing activities
Operating cash flow	3.68%-9.39M	-65.29%-25.25M	38.44%-3.08M	-319.15%-6.68M	-36.79%-5.74M	-117.51%-9.75M	-110.85%-15.28M	-124.55%-5M	-17.22%-1.59M	-147.90%-4.2M
Investing cash flow
Cash flow from continuing investing activities		160.98%400K	0	40,100.00%400K			-656K	0	-1K
Net intangibles purchase and sale	----	160.61%400K	--0	40,100.00%400K	----	----	---660K	--0	---1K	----
Net business purchase and sale	----	--0	--0	--0	----	----	--4K	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	----	160.98%400K	--0	40,100.00%400K	----	----	---656K	--0	---1K	----
Financing cash flow
Cash flow from continuing financing activities	-48.32%7.08M	388.27%26.14M	-11.22%4.75M	-480.00%-19K	7.71M	13.7M	-46.97%5.35M	534,800.00%5.35M	-99.94%5K	0
Net issuance payments of debt	39.39%-1M	---1.65M	--0	--0	--0	---1.65M	--0	--0	--0	--0
Net common stock issuance	-47.36%8.08M	330.79%23.04M	-100.17%-9K	---19K	--7.72M	--15.35M	-40.92%5.35M	534,800.00%5.35M	--0	--0
Proceeds from stock option exercised by employees	----	94,880.00%4.75M	--4.75M	----	----	----	-99.52%5K	--0	----	----
Net other financing activities	----	----	----	--0	----	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	-48.32%7.08M	388.27%26.14M	-11.22%4.75M	-480.00%-19K	--7.71M	--13.7M	-46.97%5.35M	534,800.00%5.35M	-99.94%5K	--0
Net cash flow
Beginning cash position	100.62%2.58M	-89.17%1.29M	-3.61%907K	184.78%7.21M	-29.12%5.24M	-89.17%1.29M	31.53%11.87M	-93.31%941K	-60.50%2.53M	-8.79%7.39M
Current changes in cash	-158.44%-2.31M	112.22%1.29M	382.37%1.67M	-296.22%-6.3M	140.54%1.97M	188.18%3.95M	-471.03%-10.58M	115.54%346K	-120.65%-1.59M	-186.59%-4.85M
Effect of exchange rate changes	-100.00%-6K	--0	200.00%2K	---2K	175.00%3K	-250.00%-3K	33.33%-4K	-109.09%-2K	--0	---4K
End cash Position	-95.00%262K	100.62%2.58M	100.62%2.58M	-3.61%907K	184.78%7.21M	-29.12%5.24M	-89.17%1.29M	-89.17%1.29M	-93.31%941K	-60.50%2.53M
Free cash flow	3.68%-9.39M	-58.44%-25.25M	38.44%-3.08M	-318.88%-6.68M	-18.22%-5.74M	-117.51%-9.75M	-119.96%-15.94M	-124.55%-5M	-17.29%-1.59M	-186.83%-4.86M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall